Jan 27, 2014

Farmak has brought to market a hepatoprotective drug Larnamin

The domestic pharmaceutical company Farmak has expanded its hepatoprotective portfolio. Specialists of the company have developed and brought to market Larnamin, the drug designed to restore liver detoxification function.

The new drug is produced in the form of a concentrate for solution for infusion in 10 ml ampoules No. 10. Larnamin is used in acute and chronic liver diseases associated with its detoxification function impairment. The drug neutralizes toxic effects of alcohol, drugs and other harmful substances, cleanses the body of toxins and restores liver function.

Katerina Myrhorodska, Marketing Consultant, Farmak Marketing Department for OTC Drug Products: “Larnamin is a major element in the treatment of hepatitis, cirrhosis, viral and drug-induced liver diseases. We expect that this new drug will become a first-line treatment for patients with liver diseases in hospitals as it is a vitally important medicine that restores liver function. By the end of 2014 we plan to bring to market an oral form of Larnamin in sachets.”

Back to the News